BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26561469)

  • 1. The potential role of PHF6 as an oncogene: a genotranscriptomic/proteomic meta-analysis.
    Hajjari M; Salavaty A; Crea F; Kee Shin Y
    Tumour Biol; 2016 Apr; 37(4):5317-25. PubMed ID: 26561469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHF6 interacts with the nucleosome remodeling and deacetylation (NuRD) complex.
    Todd MA; Picketts DJ
    J Proteome Res; 2012 Aug; 11(8):4326-37. PubMed ID: 22720776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PHF6 mutations in T-cell acute lymphoblastic leukemia.
    Van Vlierberghe P; Palomero T; Khiabanian H; Van der Meulen J; Castillo M; Van Roy N; De Moerloose B; Philippé J; González-García S; Toribio ML; Taghon T; Zuurbier L; Cauwelier B; Harrison CJ; Schwab C; Pisecker M; Strehl S; Langerak AW; Gecz J; Sonneveld E; Pieters R; Paietta E; Rowe JM; Wiernik PH; Benoit Y; Soulier J; Poppe B; Yao X; Cordon-Cardo C; Meijerink J; Rabadan R; Speleman F; Ferrando A
    Nat Genet; 2010 Apr; 42(4):338-42. PubMed ID: 20228800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of PHF6 in Hematopoiesis and Hematologic Malignancies.
    Eisa YA; Guo Y; Yang FC
    Stem Cell Rev Rep; 2023 Jan; 19(1):67-75. PubMed ID: 36008597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mutation of PHF6 gene in T-cell acute lymphoblatic leukemia, acute myelogenous leukemia and hepatocellular carcinoma.
    Yoo NJ; Kim YR; Lee SH
    Acta Oncol; 2012 Jan; 51(1):107-11. PubMed ID: 21736506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional insights into the human Börjeson-Forssman-Lehmann syndrome-associated protein PHF6.
    Liu Z; Li F; Ruan K; Zhang J; Mei Y; Wu J; Shi Y
    J Biol Chem; 2014 Apr; 289(14):10069-83. PubMed ID: 24554700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHF6 mutations in adult acute myeloid leukemia.
    Van Vlierberghe P; Patel J; Abdel-Wahab O; Lobry C; Hedvat CV; Balbin M; Nicolas C; Payer AR; Fernandez HF; Tallman MS; Paietta E; Melnick A; Vandenberghe P; Speleman F; Aifantis I; Cools J; Levine R; Ferrando A
    Leukemia; 2011 Jan; 25(1):130-4. PubMed ID: 21030981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pan-cancer analysis of gain-of-functional mutations to identify the common oncogenic signatures in multiple cancers.
    Wee Y; Liu Y; Bhyan SB; Lu J; Zhao M
    Gene; 2019 May; 697():57-66. PubMed ID: 30796966
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kurzer JH; Weinberg OK
    Front Oncol; 2021; 11():704471. PubMed ID: 34381727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role.
    Clermont PL; Sun L; Crea F; Thu KL; Zhang A; Parolia A; Lam WL; Helgason CD
    Br J Cancer; 2014 Oct; 111(8):1663-72. PubMed ID: 25225902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genome-scale in vivo loss-of-function screen identifies Phf6 as a lineage-specific regulator of leukemia cell growth.
    Meacham CE; Lawton LN; Soto-Feliciano YM; Pritchard JR; Joughin BA; Ehrenberger T; Fenouille N; Zuber J; Williams RT; Young RA; Hemann MT
    Genes Dev; 2015 Mar; 29(5):483-8. PubMed ID: 25737277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From oncogene to network addiction: the new frontier of cancer genomics and therapeutics.
    Tonon G
    Future Oncol; 2008 Aug; 4(4):569-77. PubMed ID: 18684067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHF6 Degrees of Separation: The Multifaceted Roles of a Chromatin Adaptor Protein.
    Todd MA; Ivanochko D; Picketts DJ
    Genes (Basel); 2015 Jun; 6(2):325-52. PubMed ID: 26103525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-Cancer Mutational and Transcriptional Analysis of the Integrator Complex.
    Federico A; Rienzo M; Abbondanza C; Costa V; Ciccodicola A; Casamassimi A
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive overview of oncogenic pathways in human cancer.
    Li F; Wu T; Xu Y; Dong Q; Xiao J; Xu Y; Li Q; Zhang C; Gao J; Liu L; Hu X; Huang J; Li X; Zhang Y
    Brief Bioinform; 2020 May; 21(3):957-969. PubMed ID: 31155677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic aspects of breast cancer progression and therapy.
    Byler S; Goldgar S; Heerboth S; Leary M; Housman G; Moulton K; Sarkar S
    Anticancer Res; 2014 Mar; 34(3):1071-7. PubMed ID: 24596345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intrinsically disordered region of methyl-CpG binding domain protein 2 (MBD2) recruits the histone deacetylase core of the NuRD complex.
    Desai MA; Webb HD; Sinanan LM; Scarsdale JN; Walavalkar NM; Ginder GD; Williams DC
    Nucleic Acids Res; 2015 Mar; 43(6):3100-13. PubMed ID: 25753662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein and gene expression analysis of Phf6, the gene mutated in the Börjeson-Forssman-Lehmann Syndrome of intellectual disability and obesity.
    Voss AK; Gamble R; Collin C; Shoubridge C; Corbett M; Gécz J; Thomas T
    Gene Expr Patterns; 2007 Oct; 7(8):858-71. PubMed ID: 17698420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new face of Borjeson-Forssman-Lehmann syndrome? De novo mutations in PHF6 in seven females with a distinct phenotype.
    Zweier C; Kraus C; Brueton L; Cole T; Degenhardt F; Engels H; Gillessen-Kaesbach G; Graul-Neumann L; Horn D; Hoyer J; Just W; Rauch A; Reis A; Wollnik B; Zeschnigk M; Lüdecke HJ; Wieczorek D
    J Med Genet; 2013 Dec; 50(12):838-47. PubMed ID: 24092917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Börjeson-Forssman-Lehmann Syndrome due to a novel plant homeodomain zinc finger mutation in the PHF6 gene.
    Mangelsdorf M; Chevrier E; Mustonen A; Picketts DJ
    J Child Neurol; 2009 May; 24(5):610-4. PubMed ID: 19264739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.